Evidence map›Paper›PMID 36677695›Full record

ArticleMolecules (Basel, Switzerland)2023

Myogenesis and Analysis of Antimicrobial Potential of Silver Nanoparticles (AgNPs) against Pathogenic Bacteria.

Palwasha Hayat, Ibrar Khan, Aneela Rehman, Tayyaba Jamil, Azam Hayat, Mujaddad Ur Rehman, Najeeb Ullah, Abid Sarwar, Amnah A Alharbi, Anas S Dablool and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Green Synthesis and Characterization of Silver Nanoparticles UsingInternational journal of microbiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Medicine and pharmacy reports · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. Phyto-synthesized silver nanoparticles fromFrontiers in plant science · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. ACS omega · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Palwasha HayatDepartment of Microbiology, Abbottabad University of Science & Technology, Havelian 22010, Pakistan.
Ibrar KhanDepartment of Microbiology, Abbottabad University of Science & Technology, Havelian 22010, Pakistan.ORCID 0000-0003-4860-9344
Aneela RehmanDepartment of Microbiology, Abbottabad University of Science & Technology, Havelian 22010, Pakistan.
Tayyaba JamilDepartment of Microbiology, Abbottabad University of Science & Technology, Havelian 22010, Pakistan.
Azam HayatDepartment of Microbiology, Abbottabad University of Science & Technology, Havelian 22010, Pakistan.
Mujaddad Ur RehmanDepartment of Microbiology, Abbottabad University of Science & Technology, Havelian 22010, Pakistan.
Najeeb UllahDepartment of Microbiology, Abbottabad University of Science & Technology, Havelian 22010, Pakistan.
Abid SarwarFood and Biotechnology Research Center, PCSIR Labs Complex Lahore, Lahore 54600, Pakistan.ORCID 0000-0003-2105-7201
Amnah A AlharbiDepartment of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0001-9879-9508
Anas S DabloolDepartment of Public Health, Health Sciences College Al-Leith, Umm Al-Qura University, Makkah 24382, Saudi Arabia.ORCID 0000-0001-6744-6259
Zubaida DaudzaiDepartment of Bioresource and Technology, King Mongkut's University of Technology Thonburi, Bangkok 10140, Thailand.
Abdulhakeem S AlamriDepartment of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0003-3174-0434
Majid AlhomraniDepartment of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0001-9798-0962
Tariq AzizSchool of Food & Biological Engineering, Jiangsu University, Zhenjiang 212013, China.ORCID 0000-0003-0905-8076
Abbottabad University of Science and Technology · PKPakistan Council of Scientific & Industrial Research · PKTaif University · SAJiangsu University · CNKing Mongkut's University of Technology Thonburi · THUmm al-Qura University · SAUniversity of Tabuk · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread and indiscriminate use of broad-spectrum antibiotics leads to microbial resistance, which causes major problems in the treatment of infectious diseases. However, advances in nanotechnology have opened up new domains for the synthesis and use of nanoparticles against multidrug-resistant pathogens. The traditional approaches for nanoparticle synthesis are not only expensive, laborious, and hazardous but also have various limitations. Therefore, new biological approaches are being designed to synthesize economical and environmentally friendly nanoparticles with enhanced antimicrobial activity. The current study focuses on the isolation, identification, and screening of metallotolerant fungal strains for the production of silver nanoparticles, using antimicrobial activity analysis and the characterization of biologically synthesized silver nanoparticles by X-ray diffraction (XRD) spectroscopy, energy-dispersive X-ray spectroscopy (EDX), and scanning electron microscopy (SEM). In total, 11 fungal isolates were isolated and screened for the synthesis of AgNPs, while the

Indexed as

Anti-Infective AgentsMetal NanoparticlesAnti-Bacterial AgentsBacteriaMicrobial Sensitivity TestsMuscle DevelopmentPlant ExtractsSilverSpectrometry, X-Ray EmissionSpectroscopy, Fourier Transform InfraredAnti-Bacterial AgentsAnti-Infective AgentsPlant ExtractsSilverEDXMDRmyogenesisPenicillium notatumSEM1silver nanoparticlesXDR

Identifiers

PMID36677695
PMCPMC9863364
OpenAlexW4313890319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.